Enter your terms above and click the 'Search' button.

Showing articles 0 to 13 of 13 Filter Applied: Lewy body disease,diffuse (Click to remove) Neuroimaging Biomarkers in a Patient with Probable Psychiatric-Onset Prodromal Dementia with Lewy Bodies Neurol 99:654-657, Urso, D.,et al, 2022 Autopsy Validation of ���I-FP-CIT Dopaminergic Neuroimaging for the Diagnosis of DLB Neurol 88:276-283, Thomas, A.J.,et al, 2017 Diagnosis and Management of Dementia with Lewy Bodies Neurol 89:88-100, McKeith, I.G.,et al, 2017 Non-Alzheimers Dementia 2 Lewy Body Dementias Lancet 386:1683-1697, Walker, Z.,et al, 2015 MRI of the Swallow Tail Sign: A Useful Marker in the Diagnosis of Lewy Body Dementia? AJNR 38:1737-1741, Shams, S.,et al, 2017 Efficacy and Safety of Cholinesterase Inhibitors and Memantine in Cognitive Impairment in Parkinsons Disease, Parkinsons Disease Dementia, and Dementia with Lewy Bodies: Systematic Review with Meta-Analysis and Trial Sequential Analysis JNNP 86:135-143, Wang, H.F.,et al, 2015 A 75-Year-Old Man With Cognitive Impairment and Gait Changes, Lewy Body Disease Neurol 69:1183-1189, Lippa,C.F.,et al, 2007 Delusions and Hallucinations in Dementia with Lewy Bodies: Worsening with Memantine Neurol 65:481-482, Ridha,B.H.,et al, 2005 Dementia with Lewy Bodies Lancet 362:1689-1690, Wilcock,G.K., 2003 Severe Worsening of Parkinsonism in Lewy Body Dementia Due to Donepezil Neurol 61:1452, Onofri,M. & Thomas,A., 2003 Diagnosing Dementia with Lewy Bodies Lancet 354:1227-1228, McKeith,I.G.,et al, 1999 Early Dopaminergic Drug-Induced Hallucinations in Parkinsonian Patients Neurol 51:811-814, Goetz,C.G.,et al, 1998 Parkinsonism-Recognition and Differential Diagnosis BMJ 310:447-452, Quinn,N., 1995 Showing articles 0 to 13 of 13